Overview

Impact of Hyperoxia During Cardiopulmonary

Status:
Completed
Trial end date:
2019-03-30
Target enrollment:
Participant gender:
Summary
The hypothesis implies that this work is the use of hyperoxia during cardiopulmonary bypass by his heart preconditioning effect is associated with a lower incidence of cardiac arrhythmias (atrial fibrillation, tachycardia or ventricular fibrillation) and lesions of myocardial ischemia-reperfusion injury in cardiac surgery postoperative.
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens